NIAID supports global research on infectious diseases, immunology, allergy and transplant science to better understand, prevent, diagnose, and treat related illnesses and conditions. With NIAID support, the discoveries of scientists in the United States and around the world are helping to improve the health of millions of individuals, advance public health policy and clinical practice, protect the United States against infectious disease threats, and promote international wellbeing. In executing its mandate, NIAID helps lead global health research and health diplomacy.
Global research is an integral part of many research projects, programs, initiatives, and other activities implemented by the Institute’s extramural and intramural divisions. The NIAID Office of Global Research (OGR) helps coordinate and facilitate these international activities.
Media Availability: Monkeys with Sudan ebolavirus Treated Successfully—Aug. 22, 2016
Media Availability: NIH Explores Connection Between Ebola Survival and Co-Infection with Malaria Parasites—Aug. 16, 2016
Media Availability: Three Vaccine Approaches Protect Monkeys Against Zika Infection—Aug. 4, 2016
NIH Begins Testing Investigational Zika Vaccine in Humans | See Q&A—Aug. 3, 2016
Media Availability: Zika Infection Is Caused by One Virus Serotype, NIH Study Finds—July 29, 2016
All Global Research News Releases
News From NIAID-Supported Institutions
Last Updated August 22, 2016